Advertisement
UK markets close in 2 hours 22 minutes

  • FTSE 100

    8,033.43
    +9.56 (+0.12%)
     

  • FTSE 250

    19,696.71
    +97.32 (+0.50%)
     

  • AIM

    753.31
    +4.13 (+0.55%)
     

  • GBP/EUR

    1.1608
    +0.0019 (+0.17%)
     

  • GBP/USD

    1.2389
    +0.0038 (+0.31%)
     

  • Bitcoin GBP

    53,351.48
    -67.01 (-0.13%)
     

  • CMC Crypto 200

    1,419.27
    +4.51 (+0.32%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    81.07
    -0.83 (-1.01%)
     

  • GOLD FUTURES

    2,325.00
    -21.40 (-0.91%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    18,057.08
    +196.28 (+1.10%)
     

  • CAC 40

    8,080.24
    +39.88 (+0.50%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Danaher wins conditional EU okay for $21 billion biopharma buy

Reuters

BRUSSELS (Reuters) - U.S. medical equipment maker Danaher <DHR.N> secured conditional EU approval on Wednesday for its $21.4 billion bid for General Electric's <GE.N> biopharma business after agreeing to sell five businesses to address competition concerns.

Danaher unveiled the deal in February, which will boost its presence in the biopharma industry, giving it access to tools for research and development of drugs.

The European Commission said Danaher will sell businesses in the United States, China, France and Britain after it voiced concerns that the deal would have reduced competition and pushed up prices of certain products in some markets.

(Reporting by Foo Yun Chee)